blincyto

Generic: blinatumomab

Labeler: amgen, inc
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name blincyto
Generic Name blinatumomab
Labeler amgen, inc
Dosage Form KIT
Manufacturer
Amgen, Inc

Identifiers & Regulatory

Product NDC 55513-160
Product ID 55513-160_3e770da4-7259-4891-a4ae-9a49ffde4f7d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA125557
Listing Expiration 2026-12-31
Marketing Start 2014-12-18

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55513160
Hyphenated Format 55513-160

Supplemental Identifiers

RxCUI
1597262 1597267

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name blincyto (source: ndc)
Generic Name blinatumomab (source: ndc)
Application Number BLA125557 (source: ndc)

Resolved Composition

Strengths
  • 35 mcg
  • 10 ml
source: label
Packaging
  • 1 KIT in 1 PACKAGE (55513-160-01) * 3.088 mL in 1 VIAL (55513-150-01) * 10.6 mL in 1 VIAL (55513-155-01)
source: ndc

Packages (1)

55513-160-01 1 KIT in 1 PACKAGE (55513-160-01) * 3.088 mL in 1 VIAL (55513-150-01) * 10.6 mL in 1 VIAL (55513-155-01)

Ingredients (0)

No ingredient records.

Linked Drug Pages (1)

BLINCYTO ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"spl_id": "3e770da4-7259-4891-a4ae-9a49ffde4f7d", "openfda": {"rxcui": ["1597262", "1597267"], "spl_set_id": ["38b482a8-960b-4591-9857-5031ecb830aa"], "manufacturer_name": ["Amgen, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 KIT in 1 PACKAGE (55513-160-01)  *  3.088 mL in 1 VIAL (55513-150-01)  *  10.6 mL in 1 VIAL (55513-155-01)", "package_ndc": "55513-160-01", "marketing_start_date": "20141218"}], "brand_name": "BLINCYTO", "product_id": "55513-160_3e770da4-7259-4891-a4ae-9a49ffde4f7d", "dosage_form": "KIT", "product_ndc": "55513-160", "generic_name": "blinatumomab", "labeler_name": "Amgen, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BLINCYTO", "application_number": "BLA125557", "marketing_category": "BLA", "marketing_start_date": "20141218", "listing_expiration_date": "20261231"}